Clinical Focus
Business Focus
Spotlight
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
New Drug Approved for Protozoal Diarrhea in Children
Nitazoxanide (Alinia), from RomarkLaboratories, has been approvedby the FDA for the treatment ofchildren who have diarrhea causedby protozoa. This agent targetsCryptosporidium parvum andGiardia lamblia.
Treatment of ProtozoalDiarrhea in Children
Nitazoxanide (Alinia), from RomarkLaboratories, has been approvedby the FDA for the treatment ofchildren who have diarrhea causedby protozoa. This agent targetsCryptosporidium parvumandGiardia lamblia.
Nitazoxanide is available onlyin liquid form and should be takenwith food. There is no restriction onfood or beverage intake or activityduring treatment.
The most common side effectsare abdominal pain, diarrhea, vomiting,and headache.
Related Videos
Related Content
